Pneomococcal Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Concomitant Administration of the Novavax Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years
Conditions:   COVID-19;   Pneumococcal Infections Interventions:   Biological: NVX;   Biological: PCV20;   Biological: Placebo Sponsor:   Medical University of Vienna Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 14, 2023 Category: Research Source Type: clinical trials

Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants
Condition:   Streptococcus Pneumoniae Infection Interventions:   Biological: 13-valent pneumococcal conjugate vaccine (multivalent conjugate);   Biological: Prevenar 13 Sponsor:   Fosun Adgenvax Biopharmaceutical Co.,Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2023 Category: Research Source Type: clinical trials